Details:

Alternative Title:
MMWR Morb Mortal Wkly Rep
Personal Author:
Wodi, A. Patricia; Ault, Kevin; Hunter, Paul; McNally, Veronica; Szilagyi, Peter G.; ... More +
Wodi, A. Patricia; Ault, Kevin; Hunter, Paul; McNally, Veronica; Szilagyi, Peter G.; Bernstein, Henry; Less -
Description:
At its October 2020 meeting, the Advisory Committee on Immunization Practices* (ACIP) approved the 2021 Recommended Child and Adolescent Immunization Schedule for Ages 18 Years or Younger. After Emergency Use Authorization of Pfizer-BioNTech COVID-19 vaccine by the Food and Drug Administration (FDA), ACIP issued an interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine in persons aged ≥16 years at its December 12, 2020, meeting (1). In addition, ACIP approved an amendment to include COVID-19 vaccine recommendations in the child and adolescent immunization schedule. After Emergency Use Authorization of Moderna COVID-19 vaccine by FDA, ACIP issued an interim recommendation for use of Moderna COVID-19 vaccine in persons aged ≥18 years at its December 19, 2020, emergency meeting (2).
Subject:
[+]
Adolescent
Advisory Committees
Child
Child, Preschool
Humans
Immunization
Immunization Schedule
Infant
Practice Guidelines As Topic
Vaccines

Source:
MMWR Morb Mortal Wkly Rep. 70(6):189-192;
Pubmed ID:
33571172
Pubmed Central ID:
PMC7877586
Document Type:
Journal Article;
Name as Subject:
Centers for Disease Control and Prevention (U.S.);
Place as Subject:
United States;
Collection(s):
Morbidity and Mortality Weekly Report (MMWR)
Main Document Checksum:
[+]
urn:sha256:50f9cd20b09a11c12e946d6e7793bbaca3ef4b53d978f1dc6367bf040f2bd038
File Type:

Supporting Files

• mm7006a1.nxml

  xml

More +